Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |